Big Pharma Quietly Pushes Back on Global Tax Deal, Citing Covid-19 Role

Big Pharma Quietly Pushes Back on Global Tax Deal, Citing Covid-19 Role

Pharma executives, lobbyists and consultants are mobilizing to fight what has become a threat to drug companies’ bottom lines: an agreement to better harmonize corporate taxation around the globe.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting